LEADER 01421nam  2200349   450 
001 9910633958403321
005 20230325174553.0
010   $a1-80356-048-7
035   $a(CKB)5700000000338778
035   $a(NjHacI)995700000000338778
035   $a(EXLCZ)995700000000338778
100   $a20230325d2022      uy             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aDrug Development Life Cycle /$fedited by Juber Akhtar [and three others]
210  1$aLondon :$cIntechOpen,$d2022.
215   $a1 online resource (110 pages)
311   $a1-80356-047-9 
330   $aDrug authentication is generally governed by critical procedures. This book presents a comprehensive overview of drug design, highlighting the steps involved from the discovery phase to product approval. Chapters address such topics as drug development processes, pharmaceutical nanoformulations and cosmeceuticals for topical use, ocular drug delivery systems, and drug development involving computer-aided drug design, machine learning, and artificial intelligence.
606   $aDrug development
615  0$aDrug development.
676   $a615.19
702   $aAkhtar$b Juber
801  0$bNjHacI
801  1$bNjHacl
906   $aBOOK
912   $a9910633958403321
996   $aDrug Development Life Cycle$92994565
997   $aUNINA